Latest Regulatory Approval News

BPH Global has secured a $1 million strategic placement to accelerate growth of its Indonesian seaweed trading operations, backed by record sales and robust infrastructure. This capital injection aims to boost trading volumes and pave the way for higher-margin revenue streams.

Champion Iron Limited has raised US$100 million through a private placement with La Caisse to help fund its proposed acquisition of Rana Gruber ASA. The deal signals a strategic push to expand Champion’s iron ore footprint in Quebec.

Maas Group Holdings is selling its Construction Materials division for $1.7 billion to Heidelberg Materials Australia, marking a strategic pivot towards electrification, digital infrastructure, and AI-led growth.

Maas Group Holdings has agreed to sell its Construction Materials division for up to $1.703 billion, marking a strategic pivot towards digital infrastructure and electrification sectors. The deal, expected to close in late 2026, includes a significant minority investment in AI infrastructure developer Firmus Grid.

BCAL Diagnostics has launched its Avantect blood tests for pancreatic and ovarian cancer with encouraging early uptake and is advancing its BREASTESTplus breast cancer test towards broader clinical use.

Santana Minerals has secured a clear statutory timeline for the Bendigo-Ophir Gold Project fast-track approval, with a decision expected by late October 2026. The appointment of a seven-member Expert Panel marks a significant step in the project's regulatory journey.

Lake Resources has clarified its latest cash flow report, highlighting $666k spent on environmental and power solution explorations while advancing key regulatory approvals for its Kachi lithium project. The company maintains a robust liquidity position and benefits from new technology partnerships aimed at reducing costs.

Australian Critical Minerals Ltd has updated its Flint Gold-Silver Project presentation, confirming drill readiness with permits and funding secured for an initial diamond drilling program in Peru’s prolific epithermal belt.

Micro-X has initiated installation of its first human pilot site for a portable Head CT scanner at Royal Melbourne Hospital, marking a pivotal step towards revolutionising stroke diagnosis with carbon nanotube technology.

TG Metals Limited has reported strong new drilling results from its Van Uden Gold Project, confirming increased gold continuity and extensions to its existing resource. Diamond core drilling has commenced, aiming to further expand the mineral resource estimate.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.